FABP7

Across TCGA pan-cancer cohorts, FABP7 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FABP7 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher FABP7 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated FABP7 expression acts as an unfavorable survival marker.

SKCM, COAD, and HNSC are the cancer types where FABP7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.167	0.730	<.001	18	view →
COAD	OS	Median	All	0.242	0.801	.023	15	view →
HNSC	OS	Median	All	0.151	0.660	.015	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FABP7–SKCM (DFS)

Open the SKCM breakdown →